Eileen Soulis

2PUBLICATIONS
22CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

|Aug 12, 2022
A Randomized, Double-Blind, Biomarker-Selected, Phase II Clinical Trial of Maintenance Poly ADP-Ribose Polymerase Inhibition With Rucaparib Following Chemotherapy for Metastatic Urothelial Carcinoma.

Simon J Crabb, Syed Hussain, Eileen Soulis

|Jul 28, 2021
Venous access devices for the delivery of long-term chemotherapy: the CAVA three-arm RCT.

Olivia Wu, Elaine McCartney, Robert Heggie

Pageof 1